Figure 9From: Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells The effect of dasatinib on cell adhesion in HCC cell lines (A, B, C). Pretreatment for 24 hours, dasatinib inhibited adhesion of sk-Hep1 and PLC/PRF/6 cells on ECM protein (A, B), but increased the adhesion of Huh-7 cells (C). ** p < 0.01 as compared with the control (student’s t-test).Back to article page